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Abstract 
Personalized medical care has been consistently proven in literature as contributing to the maintenance of psychological 
balance and quality of life in patients suffering from chronic conditions. However, limited research has investigated the role of 
personalized approach in improving these parameters in patients with advanced incurable diseases. The scope of this paper was to 
investigate the possible impact of personalized care condition in advanced colon cancer patients, requiring palliative care. 60 
patients (32 M, 28 F) (mean age 64,6) suffering from this disease were randomly assigned to a standard or to a personalized care 
condition. The latest implied (a) frequent (at least 2 monthly) meetings with the doctor, (b) possibility to be involved in treatment 
decisions, (c) more information given about diagnosis and prognosis and (d) psychological support provided to the patient and 
his/her family members, to deal better with daily problems and needs. The design of the study was prospective and consisted of two 
successive evaluations of quality of life (SF-36 questionnaire) and anxiety and depression (HAD test). Cancer patients pertaining to 
the personalized treatment approach had both superior quality of life scores (p < 0,05) and lower anxiety (p < 0,01) and depression 
(p < 0,05) than the control group. A more detailed analysis showed significant differences of vitality and social functioning for 
subjects pertaining to the study group (p < 0,05), as well as a lower ratio between  latent and manifest anxiety (p < 0,01). These 
results argue in favor of the benefits of a personalized treatment approach for patients with advanced incurable diseases.  
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Background 
Colonic cancer is one of the most important 
health problems in developed countries, being placed on 
a leading 3rd position (after stomach and lung neoplasms) 
among the most common forms of cancer [1].  
The advanced form of colonic cancer is 
considered the condition where at presentation the cancer 
is either metastatic or so locally advanced that surgical 
resection is unlikely to be carried out with a curative 
intent. Typically, a combination of palliative therapeutic 
resources (chemotherapy, radiotherapy and conservative 
surgery) is used in this case, but all these techniques are 
likely to affect the quality of life of patients, via significant 
side effects and / or emerging lifestyle restrictions [2]. In 
this context, the quality of the doctor-patient relationship 
can become a key factor for prognosis: it can moderate 
or, reversely, contribute to further depreciation of patients' 
quality of life, and, in turn, it can influence in both ways 
the adherence to the treatment. 
Studies done so far with this respect in oncology 
[3, 4] showed that involving the patient in medical 
decisions (within a so-called „personalized therapeutic 
plan”) is a potent vector that can maintain or even 
enhance one’s quality of life.  
Primary argument in favor of this position is that 
cancer patients have an immediate perspective of their 
own suffering and death; therefore, they should not only 
have the right to know the diagnosis, but also to be part of 
all critical treatment decisions [5, 6] 
Inversely, other authors claim that especially in 
situations where life expectancy is uncertain and efficacy 
of therapeutic measures is doubtful, the physician should 
be the only one to take the primary decisions [7]. The 
proponents of this view argue that information delivery, 
deliberation and decision taking are classically assumed 
only by the doctors and offering opportunities of decisions 
to patients would just contribute to their confusion [8, 9, 
10]. 
So far, advocates of the first position seem to be 
backed-up by more data, at least in the case of colonic 
cancer [11]. However, the implementation in practice of 
Received: April 20th, 2010 – Accepted: June 24th, 2010 Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
  344 
© 2010, Carol Davila University Foundation
personalized therapeutic plans is still rather rare; 
therefore, studies done so far on this topic are also rare 
and far from conclusive. 
Objectives 
The aim of this study was to evaluate the impact 
of a personalized therapeutic plan on the quality of life 
and psychological symptoms (anxiety, depression) for 
patients suffering from advanced colonic cancer and 
requiring palliative care.  
 
Our hypotheses consisted in arguing in favor of: 
 
- a positive effect of this plan on the quality of life 
of the patient (despite the multitude of physical symptoms 
brought by the disease); 
 
- a lower vulnerability to psychiatric comorbidity 
(anxiety, depression) in patients attending a personalized 
therapeutic plan.   
Materials and methods 
Participants 
The study’s number of participants was 60 
patients (32 males and 28 females) (mean age = 64,6; SD 
= 3,2) with advanced colonic cancer in the post-colectomy 
phase and who had a stable relationship with their 
oncologist in the previous two months before testing. 
Control group (n = 30) (15 males and 15 
females) (mean age = 62,7; SD = 3,1) was represented 
by patients carrying a chronic non-malignant, well 
tolerated condition (arterial systemic hypertension or 
diabetes mellitus).  
Three doctors were involved in the study (two for 
the study group and one for the control group), with no 
differences between them regarding the age, location and 
expertise.  
Inclusion and exclusion criteria  
We included in the study only patients with 
advanced colonic cancer (stage III B), in the post-surgical 
phase (after colectomy with colostomy), who had a stable 
relationship with their doctor for the last two months, were 
not treated by other doctors or health professionals, and 
consented to be subjects of this study for a 8-week 
continuous period. Patients who could not fulfill the above 
criteria, those with somatic co-morbidities that could affect 
their quality of life, and / or with neuropsychiatric disorders 
that could affect their responsibility (e.g. psychoses, 
Alzheimer) were not admitted in the study. 
Method 
Design 
The design of the study was prospective. 
Patients from both groups (colonic cancer and control) 
were randomly assigned to a standard or to a 
personalized care condition, the latest implying four 
distinct features: 
 - frequent meetings with the doctor (at least  two 
monthly); 
 - possibility of the patient to be actively involved 
into treatment decisions; 
 - more information given about the therapy and 
prognosis; 
 - psychological support provided to the patient 
and his / her family members, to deal better with the daily 
problems and needs. 
 
Participants were tested at the beginning of the 
study and after a two-month period, in which they had at 
least 3 meetings with their doctor. The variables tested 
were: 
- quality of life; 
- anxiety; 
- depression; 
- the degree of personalization of the doctor-
patient relationship (i.e. appropriateness to the patient’s 
needs), as seen by the patient. 
 
Data were collected into a database using the 
SPSS 16.0 software. The differences between scores at 
the entrance and scores at the end of the study for first 
three study variables in relationship to the fourth one were 
computed and statistically evaluated. Comparisons of 
results were done, using multivariate analysis of variance 
and paired samples t-tests. Influence of age and gender 
was controlled. All results were considered significant at a 
threshold of p < .05. 
Instruments 
1) SF-36 Quality of Life (QoL) Questionnaire [12] 
It is the most widely used instrument for the 
measurement of the quality of life (QOL). It is translated 
into numerous languages and the validity of the 8 
subscales is confirmed in general populations and in a 
wide variety of patient groups in more than 2000 articles. 
It comprises 36 questions and 8 scales, dedicated to self-
perceived functional health, general well-being, and to 
various components of physical and mental health (such 
as pain perception or vitality). Scores are reported on a 
scale from 0-100 (mean = 50, SD = 10), and are 
proportional to QoL.  Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
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2) HAD (Hospital Anxiety and Depression Scale) [13] 
It is a simple 14-items test, to evaluate anxiety 
and depression in hospital settings. Each item is 
answered by the patient on a four point (0–3) response 
category, with scores of 11 or higher - for either subscale 
- indicating probable presence of a mood disorder and a 
score of 8 to 10 being just suggestive of the presence of 
the respective state. 
 
3) An original questionnaire (8 questions) (appendix 1)  
Was designed to evaluate the degree of 
personalization of the relationship, as it is perceived by 
the patient. Answers were coded numerically (1...4 or 
1...5), with scores proportional to the degree of 
personalization of the approach. The range of answers 
was 8 to 39; scores above 26 (upper 1/3) were 
considered relevant for a personalized approach. 
Results 
Not surprisingly, the components of the quality of 
life were different across clinical conditions, with 
consistently lower SF-36 scores obtained by cancer 
patients: 
 
 
 
 
 
SF-36 scale  F  p 
General health  46,17  .01 
Ability to perform physical 
roles  25,67  .01 
Vitality  19,66  .01 
Physical functioning  16,52  .05 
Body pain  18,16  .05 
Social functioning  15,15  .05 
 
However, even if the quality of life was lower 
inside the two cancer groups, patients attended in a 
personalized manner had significantly higher scores of 
vitality and social functioning ( p  < 0,05), compared to 
cancer patients who were subject to standard care: 
 
 
 
 
Cancer patients (n = 60)  Non-cancer patients (n = 30)  SF-36 scales  Personalized  Standard  Personalized  Standard 
Physical functioning  66,7 
(61,3-74,7) 
64,9 
(58,6-68,8) 
76,9 
(72,2-79,6) 
73,3 
(64,7-76,1) 
Ability to perform physical roles  55,8 
(53,3-59,1) 
58,6 
(49,9-61,7) 
71,5 
(67,7-74,8) 
72,6 
(68,9-74,9) 
Bodily pain  65,6 
(62,3-66,8) 
69,6 
(61,1-77,5) 
79,3 
(74,8-81,7) 
76,2 
(66,5-84,3) 
General health  63,5 
(61,1-67,8) 
62,4 
(56,3-69,1) 
75,6 
(71,2-80,1) 
77,3 
(71,6-84,7) 
Vitality  68,3* 
(62,9-71,1) 
51,3* 
(48,6-54,3) 
74,5 
(68,1-79,9) 
72,1 
(68,3-74,6) 
Social functioning  72,3** 
(70,2-80,4) 
64,5** 
(62,8-66,9) 
86,2 
(87,7-89,7) 
88,1 
(80,9-91,3) 
Ability to perform emotional roles  76,4 
(70,9-81,7) 
75,1 
(66,4-84,2) 
79,4 
(71,5-86,1) 
78,4 
(72,1-85,2) 
Mental health  84,8 
(79,4-90,1) 
80,5 
(74,6-89,2) 
85,3 
(80,2-90,8) 
85,1 
(79,7-92,2) 
     * F = 13,74, p < .05 (ANOVA) 
   ** F = 14,15, p < .05 (ANOVA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Comparison of SF-36 components scores, across 
clinical conditions (ANOVA) 
 
Table 2  Quality of life (mean, range) across care conditions 
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3. Inside the cancer group, the global quality 
of life scores were also different by approach (F = 
19,07, p < .05). Still, the effect was not significant for 
people pertaining to the control group (F = 3,24, ns). 
This finding illustrates the comparative higher 
importance of approach type for the advanced 
cancer patients. 
4. Anxiety and depression scores were 
inversely correlated to the scores of the 
questionnaire, assessing the degree of 
personalization of the doctor-patient relationship (t = 
4.55, p < .02 and t = 2.86, p < .05, respectively). In 
other terms, this means that, as the doctor-patient 
relationship was perceived as more tailored to 
patient’s needs, there were fewer chances that after 
a period of 2 months the patient developed anxiety 
and / or depression. 
Discussions 
Although the quality of life was largely 
dependent on the disease (with lower scores 
associated to the advanced cancer condition), the 
type of doctor-patient relationship was able to 
influence significantly at least two of its components 
(vitality and social functioning). For both, the 
personalized approach proved to be more 
advantageous. This effect was met in both the study 
group and controls, but was statistically significant 
only in cancer patients. 
In terms of anxiety and depression, the 
perception of the doctor’s approach as tailored to 
patient’s needs was significantly associated with a 
lower risk of occurrence of these clinical conditions. 
This effect was obtained rather quickly, after only two 
months of sustained better doctor-patient 
communication. 
Both findings are important, as care is still 
often oriented to advanced cancer and more to 
easing the physical suffering and offering support to 
a merely passive patient, and not to maintain the 
patient as an active participant in the decisional 
process [14, 15]. 
  Maintaining vitality and social functioning in 
cancer can have in turn a direct effect on the 
disease, as it offers the prospect of a longer life 
expectancy, via enhancing the patient's resources to 
cope and to conserve his / her ability to have an 
active social life. Lower levels of anxiety and 
depression can contribute to the preservation of 
immunity capacities and to therapeutic adherence 
[16, 17], thereby also improving the patient's 
prognosis.  
The limits of the study were the low number 
of participants, incertitude about the possible social 
desirability effects and not taking into account some 
other relevant variables (e.g. personality type). 
Further research could provide more refined data in 
this matter; however, these preliminary results could 
be an argument in favor of the benefits of a 
personalized treatment approach for patients with 
advanced oncological illnesses. 
 
Appendix 1 
           
Questionnaire evaluating the degree of personalization of the 
doctor-patient relationship, as it is perceived by the patient 
 
Please answer the following 8 questions, by expressing 
honestly of your thoughts and your reflections about the 
treatment and the relationship with your current physician. The 
information you provide will be treated with confidentially and 
will be used only for research purposes 
 
1.  The information about the disease that was provided to you 
by the doctor is: 
a) not satisfactory (I don’t really know which is the disease I 
suffer from); 
b) somehow satisfactory, but not sufficient; 
c) satisfactory, but I would like to know more; 
d) almost completely satisfactory;  
e) completely satisfactory (I know enough details about my 
disease).  
 
2.    You received explanations regarding your disease: 
a) not at all; 
b) quite a few; 
c) a few; 
d) sufficient;  
e) sufficient and comprehensive (I could understand better what 
I am suffering from). 
 
3.  Were you ever asked if you would like to participate in 
treatment decisions? 
a) No, never, but I wouldn’t like to;  
b) No, but I wouldn’t mind; 
c) Yes, but I didn’t like to be part of; 
d) Yes, and I participated in such decisions. 
 
4.  Did you get any explanations about the treatment itself? 
a) not at all; 
b) quite a few; 
c) a few; 
d) sufficient;  
e) sufficient and comprehensive (I could understand better the 
treatment I got). 
 Journal of Medicine and Life Vol. 3, No. 3, July‐September 2010 
  347
© 2010, Carol Davila University Foundation
5.  You got the main information about the disease from: 
a) friends and / or neighbors;  
b) family; 
c) some person I know, who works in the medical field; 
d) the nurse;  
e) my current physician. 
 
6.  Your relationship to the medical staff that cares for you is: 
a) very distant; 
b) somehow distant; 
c) average; 
d) rather positive; 
e) very positive. 
 
7.  The relationship to your family / relatives is: 
a) very distant; 
b) somehow distant; 
c) average; 
d) rather positive; 
e) very positive. 
 
8.  What is your opinion about your doctor’s capacity to handle 
your disease?  
a) I am very pessimistic; 
b) I am rather skeptical; 
c) I am not sure, somewhere in the middle; 
d) I am somehow optimistic; 
e) I am optimistic.  
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